Nifty

:

22819.60

Sensex

:

73583.22

-486.85 (-2.09%)
-1690.23 (-2.25%)

Login

Nifty
Sensex

:
:

22819.60
73583.22

-486.85 (-2.09%)
-1690.23 (-2.25%)

Smruthi Organics Ltd.

Pharmaceuticals & Drugs

Rating :

56/99

BSE: 540686 | NSE: Not Listed

Watchlist

NSE BSE

106.90

27-Mar-2026

Open
High
Low
Previous Close

108.85
108.85
104.25
108.85

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4883
520626
108.85
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

122.36
26.67
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

130.46
1.40%
1.69

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.50
-0.08
-3.69

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.39
-15.67
4.47

PAT CAGR (%)

10 Years
5 Years
3 Years

17.33
-26.95
-4.83

P:E (Median)

8 Years
5 Years
3 Years

23.71
30.76
40.13

P:BV (Average)

8 Years
5 Years
3 Years

2.91
3.07
2.34

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.06
14.70
16.14

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 22.29 31.25 -28.67% 31.59 29.39 7.49% 18.99 27.27 -30.36% 38.09 39.66 -3.96%
Expenses 18.29 27.09 -32.48% 26.59 26.50 0.34% 18.76 26.83 -30.08% 33.41 35.57 -6.07%
EBITDA 4.00 4.16 -3.85% 5.01 2.90 72.76% 0.23 0.45 -48.89% 4.68 4.09 14.43%
EBIDTM 17.95% 13.32% 15.86% 9.85% 1.21% 1.64% 12.28% 10.30%
Other Income 0.01 0.00 0 0.01 0.01 0.00% 0.09 0.00 0 0.08 0.06 33.33%
Interest 0.25 0.51 -50.98% 0.66 0.44 50.00% 0.46 0.41 12.20% 0.52 0.37 40.54%
Depreciation 1.67 1.37 21.90% 1.51 1.33 13.53% 1.41 1.29 9.30% 1.50 1.59 -5.66%
PBT 1.63 2.29 -28.82% 2.85 1.13 152.21% -1.55 -1.25 - 2.74 2.19 25.11%
Tax 0.24 0.81 -70.37% 0.79 0.36 119.44% -0.46 -0.33 - 0.51 0.67 -23.88%
PAT 1.40 1.48 -5.41% 2.06 0.78 164.10% -1.09 -0.92 - 2.23 1.52 46.71%
PATM 6.26% 4.74% 6.51% 2.64% -5.77% -3.38% 5.85% 3.83%
EPS 1.22 1.30 -6.15% 1.80 0.68 164.71% -0.96 -0.81 - 1.96 1.33 47.37%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 110.96 126.01 127.64 141.04 133.37 126.50 131.07 137.41 97.34 79.35 73.78 Net Sales Growth -13.02% -1.28% -9.50% 5.75% 5.43% -3.49% -4.61% 41.16% 22.67% 7.55% Cost Of Goods Sold 53.23 68.61 72.35 91.47 80.06 66.46 83.48 90.54 60.78 48.95 42.52 Gross Profit 57.73 57.40 55.29 49.56 53.31 60.04 47.59 46.87 36.57 30.40 31.25 GP Margin 52.02% 45.55% 43.32% 35.14% 39.97% 47.46% 36.31% 34.11% 37.57% 38.31% 42.36% Total Expenditure 97.05 113.84 115.69 131.26 114.94 97.97 115.84 120.82 94.08 69.40 63.18 Power & Fuel Cost - 11.55 10.03 9.43 8.80 8.86 10.63 10.42 9.67 8.36 7.28 % Of Sales - 9.17% 7.86% 6.69% 6.60% 7.00% 8.11% 7.58% 9.93% 10.54% 9.87% Employee Cost - 17.35 17.16 15.82 13.73 11.79 13.57 12.86 9.27 7.95 7.48 % Of Sales - 13.77% 13.44% 11.22% 10.29% 9.32% 10.35% 9.36% 9.52% 10.02% 10.14% Manufacturing Exp. - 10.07 9.29 8.48 7.23 2.99 3.07 2.73 1.67 0.89 0.98 % Of Sales - 7.99% 7.28% 6.01% 5.42% 2.36% 2.34% 1.99% 1.72% 1.12% 1.33% General & Admin Exp. - 1.79 2.10 2.03 1.41 7.01 3.41 2.39 3.66 2.61 2.58 % Of Sales - 1.42% 1.65% 1.44% 1.06% 5.54% 2.60% 1.74% 3.76% 3.29% 3.50% Selling & Distn. Exp. - 2.71 2.18 1.31 1.11 0.86 1.02 1.33 1.07 0.65 2.34 % Of Sales - 2.15% 1.71% 0.93% 0.83% 0.68% 0.78% 0.97% 1.10% 0.82% 3.17% Miscellaneous Exp. - 1.77 2.57 2.71 2.60 0.00 0.65 0.54 7.97 0.00 2.34 % Of Sales - 1.40% 2.01% 1.92% 1.95% 0% 0.50% 0.39% 8.19% 0% 0% EBITDA 13.92 12.17 11.95 9.78 18.43 28.53 15.23 16.59 3.26 9.95 10.60 EBITDA Margin 12.55% 9.66% 9.36% 6.93% 13.82% 22.55% 11.62% 12.07% 3.35% 12.54% 14.37% Other Income 0.19 0.11 0.08 0.11 0.58 0.56 4.42 0.88 0.21 0.98 0.45 Interest 1.89 1.87 1.41 0.82 0.98 1.09 3.18 3.58 4.09 4.37 5.12 Depreciation 6.09 5.50 5.65 4.57 4.26 3.95 4.39 4.14 4.07 3.97 4.33 PBT 5.67 4.90 4.97 4.49 13.77 24.06 12.09 9.76 -4.68 2.59 1.59 Tax 1.08 1.34 1.38 0.36 3.39 6.95 3.64 2.89 -1.47 1.01 0.87 Tax Rate 19.05% 27.35% 27.77% 8.02% 24.62% 28.89% 30.11% 29.61% 31.41% 39.00% 54.72% PAT 4.60 3.56 3.59 4.13 10.38 17.11 8.45 6.86 -3.21 1.58 0.72 PAT before Minority Interest 4.60 3.56 3.59 4.13 10.38 17.11 8.45 6.86 -3.21 1.58 0.72 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.15% 2.83% 2.81% 2.93% 7.78% 13.53% 6.45% 4.99% -3.30% 1.99% 0.98% PAT Growth 60.84% -0.84% -13.08% -60.21% -39.33% 102.49% 23.18% - - 119.44% EPS 4.04 3.12 3.15 3.62 9.11 15.01 7.41 6.02 -2.82 1.39 0.63

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 71.63 69.62 68.16 67.16 60.49 42.46 36.38 29.06 32.27 30.69 Share Capital 11.45 11.45 11.45 11.45 11.45 3.82 3.82 3.82 3.82 3.82 Total Reserves 60.18 58.17 56.71 55.72 49.05 38.65 32.56 25.25 28.46 26.87 Non-Current Liabilities 9.04 6.51 2.01 4.85 5.20 7.38 7.40 7.29 10.79 32.38 Secured Loans 8.13 5.56 0.59 0.00 0.32 0.66 1.16 4.88 6.87 12.69 Unsecured Loans 0.00 0.00 0.00 0.11 0.18 1.35 1.34 1.34 1.35 1.35 Long Term Provisions 0.00 0.00 0.28 2.58 2.47 0.00 0.00 0.00 0.00 0.00 Current Liabilities 32.37 42.84 36.88 15.60 26.13 37.90 57.13 47.58 42.38 39.41 Trade Payables 15.99 28.64 24.66 11.06 14.00 22.18 29.89 21.57 16.51 14.93 Other Current Liabilities 5.63 4.51 2.70 1.63 0.34 1.90 1.91 3.00 6.59 6.96 Short Term Borrowings 5.97 4.46 4.85 2.72 9.58 13.64 25.18 23.01 18.71 17.19 Short Term Provisions 4.78 5.22 4.67 0.19 2.21 0.19 0.15 0.00 0.58 0.33 Total Liabilities 113.04 118.97 107.05 87.61 91.82 87.74 100.91 83.93 85.44 102.48 Net Block 44.97 39.99 37.04 33.33 31.00 31.70 29.94 30.27 29.73 32.24 Gross Block 140.98 130.51 122.20 113.93 107.34 104.09 98.02 94.22 29.73 88.14 Accumulated Depreciation 96.01 90.51 85.17 80.59 76.34 72.39 68.08 63.95 0.00 55.89 Non Current Assets 48.41 42.77 40.34 35.11 32.74 34.71 35.58 32.76 41.18 58.39 Capital Work in Progress 2.55 1.43 1.99 0.80 0.84 0.19 1.69 0.53 1.30 1.09 Non Current Investment 0.16 0.13 0.12 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Long Term Loans & Adv. 0.38 1.20 1.09 0.83 0.78 2.51 3.52 1.49 9.53 25.02 Other Non Current Assets 0.35 0.01 0.10 0.09 0.07 0.25 0.38 0.41 0.57 0.00 Current Assets 64.63 76.20 66.70 52.50 59.08 53.04 65.33 51.18 44.26 44.09 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 28.31 29.78 23.99 19.93 18.13 17.09 22.70 21.05 19.44 19.35 Sundry Debtors 32.47 41.03 36.96 28.50 21.35 24.57 36.39 25.26 21.08 19.29 Cash & Bank 0.51 0.57 1.75 0.57 16.14 3.57 4.16 1.73 1.57 1.63 Other Current Assets 3.34 0.72 0.50 0.89 3.46 7.81 2.08 3.13 2.17 3.83 Short Term Loans & Adv. 2.59 4.10 3.50 2.61 0.45 2.94 0.76 0.69 0.64 1.05 Net Current Assets 32.26 33.36 29.83 36.90 32.95 15.14 8.19 3.59 1.88 4.67 Total Assets 113.04 118.97 107.04 87.61 91.82 87.75 100.91 83.94 85.44 102.48

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 9.98 4.40 12.11 2.17 22.82 21.43 12.07 5.14 9.17 13.97 PBT 5.11 5.18 4.87 13.77 24.06 12.09 9.76 -4.68 2.59 1.59 Adjustment 7.08 6.47 5.37 4.93 4.48 7.31 7.40 7.33 7.28 7.92 Changes in Working Capital -0.02 -6.20 3.08 -12.69 0.17 5.03 -5.34 2.53 -0.59 4.01 Cash after chg. in Working capital 12.16 5.44 13.32 6.01 28.71 24.43 11.82 5.18 9.29 13.52 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.19 -1.04 -1.22 -3.84 -5.88 -3.00 0.25 -0.04 -0.11 0.45 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -11.42 -7.16 -10.25 7.15 -3.40 -4.52 -4.50 -3.21 -0.48 0.16 Net Fixed Assets -11.59 -7.75 -9.46 -6.55 -3.90 -4.57 -4.96 -63.72 58.20 -1.27 Net Investments -0.03 -0.01 -0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.20 0.60 -0.72 13.70 0.50 0.05 0.46 60.51 -58.68 1.43 Cash from Financing Activity 1.40 2.66 -1.52 -12.11 -6.86 -17.49 -5.15 -1.77 -8.68 -14.19 Net Cash Inflow / Outflow -0.04 -0.11 0.34 -2.79 12.57 -0.58 2.43 0.16 0.02 -0.06 Opening Cash & Equivalents 0.48 0.59 0.24 3.03 3.57 4.16 1.73 1.57 1.55 1.69 Closing Cash & Equivalent 0.44 0.48 0.59 0.24 16.14 3.57 4.16 1.73 1.57 1.63

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 62.58 60.82 59.55 58.68 52.85 37.10 31.78 25.39 28.20 26.81 ROA 3.07% 3.18% 4.24% 11.57% 19.05% 8.96% 7.42% -3.79% 1.69% 0.69% ROE 5.04% 5.21% 6.11% 16.27% 33.23% 21.43% 20.97% -10.48% 5.03% 2.41% ROCE 7.98% 8.22% 7.39% 21.00% 39.08% 25.00% 21.54% -0.96% 10.60% 9.53% Fixed Asset Turnover 0.94 1.05 1.20 1.21 1.20 1.30 1.43 1.58 1.45 0.90 Receivable days 105.63 107.56 84.30 68.12 66.25 84.89 81.88 86.34 86.46 94.93 Inventory Days 83.47 74.16 56.56 52.02 50.80 55.39 58.11 75.46 83.10 86.17 Payable days 118.73 134.43 71.26 57.14 99.35 82.51 73.53 82.13 79.90 82.59 Cash Conversion Cycle 70.37 47.29 69.60 63.01 17.70 57.77 66.46 79.67 89.66 98.51 Total Debt/Equity 0.23 0.17 0.08 0.04 0.17 0.37 0.76 1.06 0.99 1.19 Interest Cover 3.62 4.53 6.46 15.00 23.00 4.80 3.72 -0.15 1.59 1.31

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Smruthi Organics receives CEP certificate from EDQM
9th Mar 2026, 11:50 AM

The company has received certificate of suitability for its product Amlodipine Besilate
Read More
Smruthi Organics - Quarterly Results
14th Feb 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback